HollyBrianneLindsayMD

Pediatric Hematology & Oncology • Aurora, CO

Physician

Join to view full profile

Dr. Lindsay is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lindsay's full profile

Already have an account?

Office
13123 E 16th Ave
Aurora, CO 80045
Phone+1 720-777-1234

Fax+1 832-825-4038

Education & Training

Baylor College of MedicineFellowship, Clinical Pharmacology, 2013 - 2016
Baylor College of MedicineMS, Clinical Scientist Training Program, 2013 - 2016
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2012 - 2015
Children's Hospital Los AngelesResidency, Pediatrics, 2009 - 2012
Washington University in St. Louis School of MedicineClass of 2009

Certifications & Licensure

CO State Medical License 2023 - 2025
TX State Medical License 2015 - 2025
CA State Medical License 2011 - 2020
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
American Board of Clinical PharmacologyCertification in Clinical Pharmacology

Clinical Trials

Phase I Study of APX005M in Pediatric CNS Tumors Start of enrollment: 2018 Mar 01
Active, not recruiting
Phase 1
Fimepinostat in Treating Brain Tumors in Children and Young Adults Start of enrollment: 2019 Aug 07
Active, not recruiting
Early Phase 1
Roles: Contact

Publications & Presentations

PubMed

98 citations
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.
Jo Lynne Rokita, Komal S. Rathi, Maria F. Cardenas, Kristen A. Upton, Joy Jayaseelan
Cell Reports. 2019-11-05
2 citations
The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma.
Mohammad H Abu-Arja, Austin L Brown, Jack M Su, M Fatih Okcu, Holly B Lindsay
Neuro-Oncology. 2024-10-03
61 citations
A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor
Patrick Sin-Chan, Iqra Mumal, Tannu Suwal, Ben Ho, Xiaolian Fan
Cancer Cell. 2019-07-08

Press Mentions

Boy, 9, Had Double Vision. His Parents Thought He Needed Glasses. It Was a Brain TumorMay 24th, 2023
New Phase 1 Clinical Trial for Pediatric CNS TumorsFebruary 24th, 2022